ID: ALA3752459

Max Phase: Preclinical

Molecular Formula: C8H10N2O3

Molecular Weight: 182.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(C(=O)O)c(C)nc1CO

Standard InChI:  InChI=1S/C8H10N2O3/c1-4-6(3-11)9-5(2)7(10-4)8(12)13/h11H,3H2,1-2H3,(H,12,13)

Standard InChI Key:  PHNKNJUOTGXFNU-UHFFFAOYSA-N

Associated Targets(non-human)

Heart 1007 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 182.18Molecular Weight (Monoisotopic): 182.0691AlogP: 0.28#Rotatable Bonds: 2
Polar Surface Area: 83.31Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.43CX Basic pKa: 0.17CX LogP: -0.84CX LogD: -4.28
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.69Np Likeness Score: -0.25

References

1. Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J..  (2016)  Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.,  26  (3): [PMID:26725025] [10.1016/j.bmcl.2015.12.072]
2. Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J..  (2016)  Synthesis and positive inotropic activity evaluation of liguzinediol metabolites.,  26  (3): [PMID:26725025] [10.1016/j.bmcl.2015.12.072]

Source